Project AgeTuneUp

📍 Somerville, United States🗓 Founded 2015
Biotechnology Research🌐 agetuneup.com
Website LinkedIn
Project AgeTuneUp is making the future of DNA Repair drugs accessible to the masses. Based on research out of Harvard Medical School, and supported by the entrepreneurship community of MIT Sandbox, were taking naturally-occurring compounds that have been demonstrated to repair DNA in mice, and making them affordable enough for human use. Our first molecule is nicotinamide mononucleotide (NMN). Not only has molecule been demonstrated to be useful in mouse models of cardiac disease, but it could potentially be used to reduce the effects of radiation exposure in cancer patients (and someday, Astronauts). By using advances in machine learning such as genetic algorithms and symbolic regression, were reducing the cost of this molecule from $1000/gram, to $10/gram. More information coming in Q3 2017.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2015
Founded

Investors

0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was Project AgeTuneUp founded?
Project AgeTuneUp was founded in 2015.
What industry is Project AgeTuneUp in?
Project AgeTuneUp operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Project AgeTuneUp based?
Project AgeTuneUp is headquartered in Somerville, United States.